Life Sciences Tools & Services Companies By Book Value Per Share Ratio

Book Value Per Share
Book Value Per ShareEfficiencyMarket RiskExp Return
1BIO Bio Rad Laboratories
267.46
 0.02 
 2.33 
 0.06 
2TMO Thermo Fisher Scientific
128.08
(0.17)
 1.24 
(0.21)
3ICLR ICON PLC
118.39
(0.16)
 3.45 
(0.56)
4CRL Charles River Laboratories
73.97
 0.03 
 2.58 
 0.09 
5RVTY Revvity
64.88
(0.02)
 1.64 
(0.03)
6AZTA Azenta Inc
38.82
(0.01)
 2.60 
(0.02)
7IQV IQVIA Holdings
38.37
(0.17)
 1.86 
(0.32)
8RGEN Repligen
35.53
 0.05 
 3.10 
 0.14 
9MLAB Mesa Laboratories
29.79
(0.01)
 3.49 
(0.04)
10MEDP Medpace Holdings
28.42
 0.00 
 2.94 
 0.00 
11WAT Waters
27.0
 0.08 
 2.95 
 0.24 
12A Agilent Technologies
20.53
 0.00 
 1.63 
 0.00 
13FTRE Fortrea Holdings
16.87
 0.01 
 5.05 
 0.03 
14QGEN Qiagen NV
15.88
(0.02)
 1.26 
(0.02)
15TECH Bio Techne Corp
13.46
 0.05 
 2.35 
 0.11 
16ILMN Illumina
13.45
 0.08 
 2.30 
 0.19 
17BRKR Bruker
11.92
(0.06)
 2.68 
(0.16)
18QTRX Quanterix Corp
8.77
 0.02 
 4.04 
 0.10 
19AVTR Avantor
8.16
(0.18)
 1.47 
(0.27)
20NEO NeoGenomics
7.09
 0.08 
 2.66 
 0.21 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation. The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.